Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer.
Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer. — المؤلف: Kusumoto, Tetsuya — ESMO open 2018
- المؤلف
- Kusumoto, Tetsuya
- النشر
- ESMO open 2018
- الوصف
- e000428 p.